title: Application of Caco-2 cell line in herb-drug interaction studies: current approaches and challenges.
abstract: The Caco-2 model is employed in pre-clinical investigations to predict the likely gastrointestinal permeability of drugs because it expresses cytochrome P450 enzymes, transporters, microvilli and enterocytes of identical characteristics to the human small intestine. The FDA recommends this model as integral component of the Biopharmaceutics Classification System (BCS). Most dedicated laboratories use the Caco-2 cell line to screen new chemical entities through prediction of its solubility, bioavailability and the possibility of drug-drug or herb-drug interactions in the gut lumen. However, challenges in the inherent characteristics of Caco-2 cell and inter-laboratory protocol variations have resulted to generation of irreproducible data. These limitations affect the extrapolation of data from pre-clinical research to clinical studies involving drug-drug and herb-drug interactions. This review addresses some of these caveats and enumerates the plausible current and future approaches to reduce the anomalies associated with Caco-2 cell line investigations focusing on its application in herb-drug interactions.
authors.affiliation: Division of Clinical Pharmacology, Faculty of Medicine and Health Sciences, University of Stellenbosch, Tygerberg, Cape Town, South Africa.
authors.forename: Charles
authors.initials: C
authors.lastname: Awortwe
authors.forename: P S
authors.initials: PS
authors.lastname: Fasinu
authors.forename: B
authors.initials: B
authors.lastname: Rosenkranz
mesh_terms: D001682:Biological Availability; D018938:Caco-2 Cells / Q000187:drug effects*; D002470:Cell Survival; D004353:Drug Evaluation, Preclinical / Q000379:methods; D041743:Herb-Drug Interactions; D006801:Humans; D007408:Intestinal Absorption
references.citation: Xenobiotica. 2002 Jun;32(6):451-78
references.pmid: 12160480
references.citation: Pharm Res. 2000 Oct;17(10):1175-80
references.pmid: 11145221
references.citation: Eur J Pharm Biopharm. 2002 Nov;54(3):319-24
references.pmid: 12445562
references.citation: J Pharm Sci. 2004 Jul;93(7):1743-54
references.pmid: 15176063
references.citation: Pharm Res. 2002 Oct;19(10):1495-501
references.pmid: 12425467
references.citation: Drug Metab Dispos. 2005 Jul;33(7):937-46
references.pmid: 15821044
references.citation: Curr Opin Drug Discov Devel. 2004 Jan;7(1):49-61
references.pmid: 14982148
references.citation: Hepatology. 1997 Dec;26(6):1467-76
references.pmid: 9397986
references.citation: Biochem Biophys Res Commun. 1991 Mar 29;175(3):880-5
references.pmid: 1673839
references.citation: Curr Drug Saf. 2012 Apr;7(2):120-5
references.pmid: 22873496
references.citation: Int J Cancer. 1991 Nov 11;49(5):721-30
references.pmid: 1937958
references.citation: Drug Metab Rev. 2004 Feb;36(1):57-104
references.pmid: 15072439
references.citation: J Pharm Sci. 1996 Feb;85(2):165-9
references.pmid: 8683442
references.citation: Gastroenterology. 2001 Feb;120(2):525-33
references.pmid: 11159893
references.citation: J Ethnopharmacol. 2012 Dec 18;144(3):612-7
references.pmid: 23064285
references.citation: Clin Pharmacol Ther. 2004 Jun;75(6):546-57
references.pmid: 15179409
references.citation: Curr Drug Metab. 2010 Nov;11(9):730-42
references.pmid: 21189135
references.citation: Pharmacotherapy. 2000 Jan;20(1):83-7
references.pmid: 10641978
references.citation: EMBO J. 1984 Nov;3(11):2687-94
references.pmid: 6391916
references.citation: Mol Pharmacol. 2005 Mar;67(3):923-8
references.pmid: 15598971
references.citation: Oncologist. 2007 Aug;12(8):927-41
references.pmid: 17766652
references.citation: Curr Drug Metab. 2007 Dec;8(8):787-802
references.pmid: 18220559
references.citation: Gastroenterology. 1989 Mar;96(3):736-49
references.pmid: 2914637
references.citation: Crit Rev Ther Drug Carrier Syst. 1991;8(4):305-30
references.pmid: 1769065
references.citation: Expert Opin Drug Metab Toxicol. 2007 Aug;3(4):469-89
references.pmid: 17696800
references.citation: J Hepatol. 2000 Nov;33(5):853-5
references.pmid: 11097498
references.citation: J Pharmacol Exp Ther. 2001 Oct;299(1):164-70
references.pmid: 11561076
references.citation: J Pharm Sci. 2002 Mar;91(3):669-79
references.pmid: 11920752
references.citation: Xenobiotica. 2008 Jul;38(7-8):1140-64
references.pmid: 18668443
references.citation: Drug Discov Today. 2005 Mar 1;10(5):335-43
references.pmid: 15749282
references.citation: Biotechnol Prog. 2006 Jan-Feb;22(1):186-98
references.pmid: 16454510
references.citation: Arch Pharm Res. 2004 Apr;27(4):429-35
references.pmid: 15180309
references.citation: J Clin Pharmacol. 2002 Jun;42(6):620-43
references.pmid: 12043951
references.citation: Pharm Res. 2003 Aug;20(8):1163-9
references.pmid: 12948013
references.citation: Mol Pharm. 2006 Nov-Dec;3(6):686-94
references.pmid: 17140256
references.citation: Adv Drug Deliv Rev. 2001 Oct 1;50 Suppl 1:S33-40
references.pmid: 11576694
references.citation: Biochim Biophys Acta. 2002 Jan 30;1542(1-3):149-59
references.pmid: 11853888
references.citation: J Pharm Sci. 1972 Jan;61(1):70-4
references.pmid: 5019220
references.citation: Xenobiotica. 2008 Jun;38(6):559-73
references.pmid: 18570158
references.citation: J Pharm Sci. 1999 Jul;88(7):680-7
references.pmid: 10393565
references.citation: Annu Rev Physiol. 2002;64:563-94
references.pmid: 11826280
references.citation: Drug Metab Dispos. 1998 Apr;26(4):343-6
references.pmid: 9531522
references.citation: Gastroenterology. 1992 Aug;103(2):414-23
references.pmid: 1634060
references.citation: Int J Pharm. 2001 Jul 3;222(1):77-89
references.pmid: 11404034
references.citation: J Pharm Sci. 1971 Sep;60(9):1338-40
references.pmid: 5567579
references.citation: Lancet. 2000 May 27;355(9218):1912
references.pmid: 10866469
references.citation: Pharm Res. 1993 May;10(5):674-81
references.pmid: 8321830
references.citation: J Natl Cancer Inst. 2000 Oct 18;92(20):1651-6
references.pmid: 11036110
references.citation: Prog Med Chem. 2003;41:1-59
references.pmid: 12774690
references.citation: Eur J Pharm Sci. 2004 Jan;21(1):25-51
references.pmid: 14706810
references.citation: Am J Kidney Dis. 2001 Nov;38(5):1105-7
references.pmid: 11684566
references.citation: Pharm Res. 2005 Aug;22(8):1287-93
references.pmid: 16078138
references.citation: Ann Pharmacother. 2000 Sep;34(9):1013-6
references.pmid: 10981246
references.citation: Front Pharmacol. 2012 Apr 30;3:69
references.pmid: 22557968
references.citation: Eur J Pharm Sci. 2004 Jan;21(1):17-24
references.pmid: 14706809
references.citation: Biochem J. 1999 Jun 15;340 ( Pt 3):715-22
references.pmid: 10359656
references.citation: J Pharm Sci. 2003 Jun;92(6):1250-61
references.pmid: 12761814
references.citation: Pharm Res. 2002 Oct;19(10):1400-16
references.pmid: 12425456
references.citation: Drug Metab Dispos. 2006 Apr;34(4):577-82
references.pmid: 16415120
references.citation: Cancer Treat Rev. 2009 Apr;35(2):137-47
references.pmid: 18986769
references.citation: J Biomol Screen. 2004 Oct;9(7):598-606
references.pmid: 15475479
references.citation: Gen Physiol Biophys. 2009 Sep;28(3):309-15
references.pmid: 20037197
references.citation: Eur J Pharm Sci. 2002 Sep;16(4-5):237-46
references.pmid: 12208453
references.citation: Int J Clin Pharmacol Ther. 2000 Oct;38(10):500-2
references.pmid: 11073292
references.citation: Pharm Res. 2003 Mar;20(3):397-405
references.pmid: 12669959
references.citation: J Biomol Screen. 2007 Feb;12(1):84-91
references.pmid: 17099244
references.citation: Sci Rep. 2012;2:298
references.pmid: 22389767
references.citation: Drug Metab Dispos. 2010 Dec;38(12):2179-87
references.pmid: 20837659
references.citation: Transplantation. 2000 May 27;69(10):2229-30
references.pmid: 10852634
references.citation: J Heart Lung Transplant. 2001 Jul;20(7):795
references.pmid: 11474706
references.citation: J Clin Psychopharmacol. 2002 Feb;22(1):46-54
references.pmid: 11799342
references.citation: Biochem Biophys Res Commun. 2004 Nov 5;324(1):365-71
references.pmid: 15465028
references.citation: Eur J Pharm Sci. 2004 Jan;21(1):77-86
references.pmid: 14706814
references.citation: Lancet. 2000 Feb 12;355(9203):548-9
references.pmid: 10683008
references.citation: Eur J Pharm Sci. 2000 Oct;11 Suppl 2:S51-60
references.pmid: 11033427
references.citation: Neuro Endocrinol Lett. 2009;30 Suppl 1:101-5
references.pmid: 20027153
references.citation: J Cell Biol. 1991 Dec;115(5):1409-18
references.pmid: 1955481
references.citation: Curr Top Med Chem. 2001 Nov;1(5):367-83
references.pmid: 11899103
references.citation: Med Clin (Barc). 2012 Feb 18;138(3):93-8
references.pmid: 21939995
references.citation: Pharm Res. 1996 Jan;13(1):120-3
references.pmid: 8668660
references.citation: Transpl Int. 2003 Jul;16(7):543-4
references.pmid: 12677367
references.citation: J Pharm Sci. 2001 Nov;90(11):1776-86
references.pmid: 11745735
references.citation: Acta Pharmacol Sin. 2002 Apr;23(4):315-22
references.pmid: 11931705
references.citation: J Pharmacol Exp Ther. 2002 Mar;300(3):1036-45
references.pmid: 11861813
references.citation: Drug Metab Dispos. 2003 Dec;31(12):1507-19
references.pmid: 14625347
references.citation: Pharm Res. 1998 Sep;15(9):1382-6
references.pmid: 9755889
references.citation: Pharm Res. 2009 Sep;26(9):2039-54
references.pmid: 19568696
references.citation: Nat Med. 2003 Feb;9(2):220-4
references.pmid: 12514743
references.citation: Eur J Pharm Sci. 2006 Jul;28(4):291-9
references.pmid: 16704924
references.citation: Clin Pharmacol Ther. 1999 Oct;66(4):338-45
references.pmid: 10546917
references.citation: J Hepatobiliary Pancreat Surg. 2002;9(4):443-7
references.pmid: 12483266
references.citation: Mol Pharm. 2005 Jan-Feb;2(1):64-73
references.pmid: 15804179
references.citation: Malar J. 2011 May 02;10:109
references.pmid: 21529379
references.citation: J Pharmacol Exp Ther. 2003 Mar;304(3):1258-67
references.pmid: 12604704
references.citation: Pharm Res. 2003 Mar;20(3):373-81
references.pmid: 12669956
references.citation: Clin Pharmacol Ther. 2005 Sep;78(3):260-77
references.pmid: 16153397
references.citation: Drug Metab Dispos. 1996 Jun;24(6):634-42
references.pmid: 8781778
references.citation: Expert Opin Drug Metab Toxicol. 2006 Aug;2(4):591-608
references.pmid: 16859407
references.citation: J Pharmacol Toxicol Methods. 2000 Jul-Aug;44(1):301-12
references.pmid: 11274897
references.citation: Clin Pharmacol Ther. 2013 Jul;94(1):95-112
references.pmid: 23588315
references.citation: Clin Pharmacol Ther. 2003 Dec;74(6):525-35
references.pmid: 14663455